Offering unique exposure at competitive prices: Haemonetics Corp. (HAE) Stock
Needham raised the price target for the Haemonetics Corp. (NYSE:HAE) stock from “a Hold” to “a Buy”. The rating was released on June 12, 2024, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on December 15, 2021, from Buy to Neutral and set the price objective to $59. […]
Recent trade makes Haemonetics Corp. (HAE) Stock an appealing buy
Needham raised the price target for the Haemonetics Corp. (NYSE:HAE) stock from “a Hold” to “a Buy”. The rating was released on Jun-13-24, according to finviz. The stock was downgraded by Citigroup, who disclosed in a research note on December 15, 2021, from Buy to Neutral and set the price objective to $59. In their […]
Mizuho raised the price target for the Haemonetics Corp. (NYSE:HAE) stock to “”a Buy””
Mizuho raised the price target for the Haemonetics Corp. (NYSE:HAE) stock to “a Buy”. The rating was released on October 13, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $59. The stock was resumed by Raymond James, who disclosed in […]
